메뉴 건너뛰기
American Journal of Gastroenterology
Volumn 103, Issue 2, 2008, Pages 267-275
Management strategy for patients with gastroesophageal reflux disease: A comparison between empirical treatment with esomeprazole and endoscopy-oriented treatment
Author keywords

[No Author keywords available]
Indexed keywords

ESOMEPRAZOLE;
EID: 39049157286     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01659.x     Document Type: Article
Times cited : (55)
References (27)
  • 1
    • 23844452717 scopus 로고    scopus 로고
    • Review article: Extraoesophageal manifestations of gastro-oesophageal reflux disease
    • Richter JE. Review article: Extraoesophageal manifestations of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005 22 (Suppl 1 70 80.
    • (2005) Aliment Pharmacol Ther , vol.22 , Issue.1 , pp. 70-80
    • Richter, J.E.1
  • 2
    • 33644869734 scopus 로고    scopus 로고
    • Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community
    • Wiklund I, Carlsson J, Vakil N. Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community. Am J Gastroenterol 2006 101 : 18 28.
    • (2006) Am J Gastroenterol , vol.101 , pp. 18-28
    • Wiklund, I.1    Carlsson, J.2    Vakil, N.3
  • 3
    • 23844556187 scopus 로고    scopus 로고
    • Review article: Gastro-oesophageal reflux disease-the extent of the problem
    • Moayyedi P, Axon AT. Review article: Gastro-oesophageal reflux disease-the extent of the problem. Aliment Pharmacol Ther 2005 22 (Suppl 1 11 9.
    • (2005) Aliment Pharmacol Ther , vol.22 , Issue.1 , pp. 11-9
    • Moayyedi, P.1    Axon, A.T.2
  • 4
    • 0037343934 scopus 로고    scopus 로고
    • Factors that influence therapeutic outcomes in symptomatic gastroesophageal reflux disease
    • Quigley EM. Factors that influence therapeutic outcomes in symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003 98 (Suppl 3 S24 30.
    • (2003) Am J Gastroenterol , vol.98 , Issue.3
    • Quigley, E.M.1
  • 5
    • 0141650562 scopus 로고    scopus 로고
    • Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease
    • Vakil N, Fennerty MB. Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease. Aliment Pharmacol Ther 2003 18 : 559 68.
    • (2003) Aliment Pharmacol Ther , vol.18 , pp. 559-68
    • Vakil, N.1    Fennerty, M.B.2
  • 6
    • 7044241085 scopus 로고    scopus 로고
    • Managing gastroesophageal reflux disease for the lifetime of the patient: Evaluating the long-term options
    • Metz DC. Managing gastroesophageal reflux disease for the lifetime of the patient: Evaluating the long-term options. Am J Med 2004 117 (Suppl 5A 49S 55S.
    • (2004) Am J Med , vol.117 , Issue.5
    • Metz, D.C.1
  • 7
    • 0032998835 scopus 로고    scopus 로고
    • An evidence-based appraisal of reflux disease management - The Genval Workshop Report
    • Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 1999 44 (Suppl 2 S1 16.
    • (1999) Gut , vol.44 , Issue.2
    • Dent, J.1    Brun, J.2    Fendrick, A.M.3
  • 8
    • 4344642267 scopus 로고    scopus 로고
    • Personal view: Rationale and proposed algorithms for symptom-based proton pump inhibitor therapy for gastro-oesophageal reflux disease
    • Bytzer P, Blum AL. Personal view: Rationale and proposed algorithms for symptom-based proton pump inhibitor therapy for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004 20 : 389 98.
    • (2004) Aliment Pharmacol Ther , vol.20 , pp. 389-98
    • Bytzer, P.1    Blum, A.L.2
  • 9
    • 0032430632 scopus 로고    scopus 로고
    • The utility of endoscopy in the management of patients with gastroesophageal reflux symptoms
    • Blustein PK, Beck PL, Meddings JB, et al. The utility of endoscopy in the management of patients with gastroesophageal reflux symptoms. Am J Gastroenterol 1998 93 : 2508 12.
    • (1998) Am J Gastroenterol , vol.93 , pp. 2508-12
    • Blustein, P.K.1    Beck, P.L.2    Meddings, J.B.3
  • 10
    • 0035835413 scopus 로고    scopus 로고
    • Management of gastro-oesopghageal reflux disease in general practice
    • Dent J, Jones R, Kahrilas P, et al. Management of gastro-oesopghageal reflux disease in general practice. BMJ 2001 322 : 344 7.
    • (2001) BMJ , vol.322 , pp. 344-7
    • Dent, J.1    Jones, R.2    Kahrilas, P.3
  • 11
    • 0032877637 scopus 로고    scopus 로고
    • Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease
    • Valle C, Broglia F, Pistorio A, et al. Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease. Dig Dis Sci 1999 44 : 1848 52.
    • (1999) Dig Dis Sci , vol.44 , pp. 1848-52
    • Valle, C.1    Broglia, F.2    Pistorio, A.3
  • 12
    • 0029933079 scopus 로고    scopus 로고
    • The endoscopic assessment of esophagitis: A progress report on observer agreement
    • Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: A progress report on observer agreement. Gastroenterology 1996 111 : 85 92.
    • (1996) Gastroenterology , vol.111 , pp. 85-92
    • Armstrong, D.1    Bennett, J.R.2    Blum, A.L.3
  • 13
    • 0032216676 scopus 로고    scopus 로고
    • Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD)
    • Wiklund IK, Junghard O, Grace E, et al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl 1998 583 41 9.
    • (1998) Eur J Surg Suppl , Issue.583 , pp. 41-9
    • Wiklund, I.K.1    Junghard, O.2    Grace, E.3
  • 14
    • 0034945209 scopus 로고    scopus 로고
    • Quality of life in patients with endoscopy-negative heartburn: Reliability and sensitivity of disease-specific instruments
    • Talley NJ, Fullerton S, Junghard O, et al. Quality of life in patients with endoscopy-negative heartburn: Reliability and sensitivity of disease-specific instruments. Am J Gastroenterol 2001 96 : 1998 2004.
    • (2001) Am J Gastroenterol , vol.96 , pp. 1998-2004
    • Talley, N.J.1    Fullerton, S.2    Junghard, O.3
  • 15
    • 39049154130 scopus 로고    scopus 로고
    • Interpretability and meaningfulness of quality of life changes in patients with heartburn
    • Wiklund IK, Fullerton S, Junghard O, et al. Interpretability and meaningfulness of quality of life changes in patients with heartburn. Gastroenterology 2000 118 (Suppl 2 A220.
    • (2000) Gastroenterology , vol.118 , Issue.2
    • Wiklund, I.K.1    Fullerton, S.2    Junghard, O.3
  • 16
    • 33746044253 scopus 로고    scopus 로고
    • Reflux rising! An essay on witnessing a disease in evolution
    • Bardhan KD, Royston C, Nayyar AK. Reflux rising! An essay on witnessing a disease in evolution. Dig Liver Dis 2006 38 : 163 8.
    • (2006) Dig Liver Dis , vol.38 , pp. 163-8
    • Bardhan, K.D.1    Royston, C.2    Nayyar, A.K.3
  • 17
    • 33846444341 scopus 로고    scopus 로고
    • Erosive esophagitis and nonerosive reflux disease (NERD): Comparison of epidemiologic, physiologic, and therapeutic characteristics
    • Fass R. Erosive esophagitis and nonerosive reflux disease (NERD): Comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol 2007 41 : 131 7.
    • (2007) J Clin Gastroenterol , vol.41 , pp. 131-7
    • Fass, R.1
  • 18
    • 0037898145 scopus 로고    scopus 로고
    • Review article: Test and treat or treat and test in reflux disease?
    • Vakil N. Review article: Test and treat or treat and test in reflux disease? Aliment Pharmacol Ther 2003 17 (Suppl 2 57 9.
    • (2003) Aliment Pharmacol Ther , vol.17 , Issue.2 , pp. 57-9
    • Vakil, N.1
  • 19
    • 0036166366 scopus 로고    scopus 로고
    • The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease
    • Ofman JJ, Dorn GH, Fennerty MB, et al. The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2002 16 : 261 73.
    • (2002) Aliment Pharmacol Ther , vol.16 , pp. 261-73
    • Ofman, J.J.1    Dorn, G.H.2    Fennerty, M.B.3
  • 20
    • 23844508159 scopus 로고    scopus 로고
    • Review article: Gastro-oesophageal reflux disease - The health economic implications
    • Mason J, Hungin APS. Review article: Gastro-oesophageal reflux disease - the health economic implications. Aliment Pharmacol Ther 2005 22 (Suppl 1 20 31.
    • (2005) Aliment Pharmacol Ther , vol.22 , Issue.1 , pp. 20-31
    • Mason, J.1    Hungin, A.P.S.2
  • 21
    • 33645049052 scopus 로고    scopus 로고
    • Pretreatment endoscopy - Pro & contra: Endoscopy is needed before treatment in all patients with gastroesophageal reflux disease
    • Pace F, Manes G, Conio M, et al. Pretreatment endoscopy - pro & contra: Endoscopy is needed before treatment in all patients with gastroesophageal reflux disease. Endoscopy 2006 38 : 271 5.
    • (2006) Endoscopy , vol.38 , pp. 271-5
    • Pace, F.1    Manes, G.2    Conio, M.3
  • 22
    • 33645079371 scopus 로고    scopus 로고
    • Pretreatment endoscopy - Pro & contra: Is endoscopy needed before treatment in all patients with gastroesophageal reflux disease?
    • Vakil N. Pretreatment endoscopy - pro & contra: Is endoscopy needed before treatment in all patients with gastroesophageal reflux disease? Endoscopy 2006 38 : 276 8.
    • (2006) Endoscopy , vol.38 , pp. 276-8
    • Vakil, N.1
  • 23
    • 13744261420 scopus 로고    scopus 로고
    • Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease
    • The American College of Gastroenterology.
    • DeVault KR, Castell DO, The American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005 100 : 190 200.
    • (2005) Am J Gastroenterol , vol.100 , pp. 190-200
    • Devault, K.R.1    Castell, D.O.2
  • 24
    • 33744733783 scopus 로고    scopus 로고
    • Impact of referral for gastro-oesophageal reflux disease on the workload of an academic gastroenterology unit
    • Cantu P, Savojardo D, Carmagnola S, et al. Impact of referral for gastro-oesophageal reflux disease on the workload of an academic gastroenterology unit. Dig Liver Dis 2005 37 : 735 40.
    • (2005) Dig Liver Dis , vol.37 , pp. 735-40
    • Cantu, P.1    Savojardo, D.2    Carmagnola, S.3
  • 25
    • 4344638500 scopus 로고    scopus 로고
    • The role of acid suppression in patients with endoscopy-negative reflux disease: The effect of treatment with esomeprazole or omeprazole
    • Armstrong D, Talley NJ, Lauritsen K, et al. The role of acid suppression in patients with endoscopy-negative reflux disease: The effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther 2004 20 : 413 21.
    • (2004) Aliment Pharmacol Ther , vol.20 , pp. 413-21
    • Armstrong, D.1    Talley, N.J.2    Lauritsen, K.3
  • 26
    • 19544389849 scopus 로고    scopus 로고
    • Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: Report from the ProGORD study
    • Malfertheiner P, Lind T, Willich S, et al. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: Report from the ProGORD study. Gut 2005 54 : 746 51.
    • (2005) Gut , vol.54 , pp. 746-51
    • Malfertheiner, P.1    Lind, T.2    Willich, S.3
  • 27
    • 0036667969 scopus 로고    scopus 로고
    • Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: A placebo-controlled trial of on-demand therapy for 6 months
    • Guarantor of the article: Prof. Vincenzo Savarino, M.D. Specific author contributions: Vincenzo Savarino was involved in the study design and was responsible for coordination and performance of the studies, subject recruitment, and drafting of the manuscript. Edoardo G. Giannini was involved in the study design, data and statistical analysis, data interpretation, and drafting of the manuscript. Pietro Dulbecco and Patrizia Zentilin were involved in the study performance, subject recruitment, and data analysis. Sergio Vigneri assisted with the study concept and drafting of the manuscript. Pamela Scarlata was involved with the drafting of the manuscript. All authors approved the final draft submitted. Financial support: This study was made possible by unrestricted grants provided by AstraZeneca, Italy.
    • Talley NJ, Venables TL, Green JR, et al. Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: A placebo-controlled trial of on-demand therapy for 6 months. Eur J Gastroenterol Hepatol 2002 14 : 857 63.
    • (2002) Eur J Gastroenterol Hepatol , vol.14 , pp. 857-63
    • Talley, N.J.1    Venables, T.L.2    Green, J.R.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.